SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-19-014714
Filing Date
2019-08-06
Accepted
2019-08-06 16:47:41
Documents
76
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f10k2018_inspyrtherapeutics.htm 10-K 1351339
2 CONSENT OF LIGGETT & WEBB, P.A. f10k2018ex23-01_inspyr.htm EX-23.01 2579
3 CERTIFICATION f10k2018ex31-1_inspyr.htm EX-31.1 9815
4 CERTIFICATION f10k2018ex31-2_inspyr.htm EX-31.2 10186
5 CERTIFICATION f10k2018ex32-1_inspyr.htm EX-32.1 7603
6 CERTIFICATION f10k2018ex32-2_inspyr.htm EX-32.2 9194
  Complete submission text file 0001213900-19-014714.txt   4680805

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE nspx-20181231.xml EX-101.INS 569533
8 XBRL CALCULATION FILE nspx-20181231_cal.xml EX-101.CAL 53712
9 XBRL DEFINITION FILE nspx-20181231_def.xml EX-101.DEF 191446
10 XBRL LABEL FILE nspx-20181231_lab.xml EX-101.LAB 407079
11 XBRL PRESENTATION FILE nspx-20181231_pre.xml EX-101.PRE 309209
12 XBRL SCHEMA FILE nspx-20181231.xsd EX-101.SCH 57603
Mailing Address 2511 N LOOP 1604 W SUITE 204 SAN ANTONIO TX 78258
Business Address 2511 N LOOP 1604 W SUITE 204 SAN ANTONIO TX 78258 (210) 479-8112
Inspyr Therapeutics, Inc. (Filer) CIK: 0001421204 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-55331 | Film No.: 191002785
SIC: 2834 Pharmaceutical Preparations